Pharma MNCs call on Russian government for criteria on localization of production

Multinational pharmaceutical producers have called on the Russian government to design clear criteria for the localization of drug production in the country, reports The Pharma Letter’s local correspondent.

According to foreign pharmaceutical producers, the current lack of clear for the localized pharmaceutical products in Russia prevents foreign drugmakers from investing in the Russian economy.

According to the MNCs, due to unclear local legislation, there is a threat that even those drugs that will be produced within the country will be considered as foreign and will not get benefits and preferences as local analogues during the participation in state tenders.